AAAAAA
Results: 1-25/29
Authors:
Ferenci, P
Citation: P. Ferenci, Hepatic encephalopathy, DEUT MED WO, 126, 2001, pp. S76-S80
Authors:
Ferenci, P
Stauber, R
Steindl-Munda, P
Gschwantler, M
Fickert, P
Datz, C
Muller, C
Hackl, F
Rainer, W
Watkins-Riedel, T
Lin, W
Krejs, GJ
Gangl, A
Citation: P. Ferenci et al., Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial, EUR J GASTR, 13(6), 2001, pp. 699-705
Authors:
Hayes, PC
Ferenci, P
Citation: Pc. Hayes et P. Ferenci, Portal hypertension - Foreword, EUR J GASTR, 13(4), 2001, pp. 307-308
Authors:
Eibl, N
Gschwantler, M
Ferenci, P
Eibl, MM
Weiss, W
Schernthaner, G
Citation: N. Eibl et al., Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha, EUR J GASTR, 13(3), 2001, pp. 295-298
A controlled study of sorbent suspension dialysis in chronic liver diseaseand hepatic encephalopathy
Authors:
Kramer, L
Gendo, A
Madl, C
Mullen, KD
Kaminski-Russ, K
Sunder-Plassmann, G
Schaffer, A
Bauer, E
Roth, E
Ferenci, P
Citation: L. Kramer et al., A controlled study of sorbent suspension dialysis in chronic liver diseaseand hepatic encephalopathy, INT J ARTIF, 24(7), 2001, pp. 434-442
Authors:
Ferenci, P
Brunner, H
Nachbaur, K
Datz, C
Gschwantler, M
Hofer, H
Stauber, R
Hackl, F
Jessner, W
Rosenbeiger, M
Munda-Steindl, P
Hegenbarth, K
Gangl, A
Vogel, W
Citation: P. Ferenci et al., Combination of interferon induction therapy and ribavirin in chronic hepatitis C, HEPATOLOGY, 34(5), 2001, pp. 1006-1011
Authors:
Zollner, G
Fickert, P
Zenz, R
Fuchsbichler, A
Stumptner, C
Kenner, L
Ferenci, P
Stauber, RE
Krejs, GJ
Denk, H
Zatloukal, K
Trauner, M
Citation: G. Zollner et al., Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases, HEPATOLOGY, 33(3), 2001, pp. 633-646
Authors:
Caca, K
Ferenci, P
Kuhn, HJ
Polli, C
Willgerodt, H
Kunath, B
Hermann, W
Mossner, J
Berr, F
Citation: K. Caca et al., High prevalence of the H1069Q mutation in East German patients with Wilsondisease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis, J HEPATOL, 35(5), 2001, pp. 575-581
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study
Authors:
Jessner, W
Gschwantler, M
Steindl-Munda, P
Hofer, H
Watkins-Riedel, T
Wrba, F
Mueller, C
Gangi, A
Ferenci, P
Citation: W. Jessner et al., Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study, LANCET, 358(9289), 2001, pp. 1241-1242
Authors:
Firneisz, G
Woller, J
Ferenci, P
Szalay, F
Citation: G. Firneisz et al., Postcremation diagnosis from an electric shaver, LANCET, 358(9275), 2001, pp. 34-34
Authors:
Nicholl, DJ
Ferenci, P
Polli, C
Burdon, MB
Pall, HS
Citation: Dj. Nicholl et al., Wilson's disease presenting in a family with an apparent dominant history of tremor, J NE NE PSY, 70(4), 2001, pp. 514-516
Authors:
Schoniger-Hekele, M
Muller, C
Kutilek, M
Oesterreicher, C
Ferenci, P
Gangl, A
Citation: M. Schoniger-hekele et al., Hepatocellular carcinoma in Central Europe: prognostic features and survival, GUT, 48(1), 2001, pp. 103-109
Authors:
Firneisz, G
Szonyi, L
Ferenci, P
Gorog, D
Nemes, B
Szalay, F
Citation: G. Firneisz et al., Wilson disease in two consecutive generations: An exceptional family, AM J GASTRO, 96(7), 2001, pp. 2269-2271
Authors:
Gombas, W
Fischer, G
Jagsch, R
Eder, H
Okamoto, I
Schindler, S
Muller, C
Ferenci, P
Kasper, S
Citation: W. Gombas et al., Prevalence and distribution of hepatitis C subtypes in patients with opioid dependence, EUR ADDIC R, 6(4), 2000, pp. 198-204
Authors:
Schoniger-Hekele, M
Muller, C
Kutilek, M
Oesterreicher, C
Ferenci, P
Gangl, A
Citation: M. Schoniger-hekele et al., Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation, EUR J GASTR, 12(8), 2000, pp. 941-948
Authors:
Ferenci, P
Citation: P. Ferenci, The importance of Helicobacter - Also beyond the stomach, ACT MED AUS, 27(4), 2000, pp. 109-111
Authors:
Kramer, L
Tribl, B
Gendo, A
Zauner, C
Schneider, B
Ferenci, P
Madl, C
Citation: L. Kramer et al., Partial pressure of ammonia versus ammonia in hepatic encephalopathy, HEPATOLOGY, 31(1), 2000, pp. 30-34
Authors:
Ferenci, P
Steindl-Munda, P
Citation: P. Ferenci et P. Steindl-munda, Triggering of acute alcoholic hepatitis by alpha-interferon therapy?, J HEPATOL, 32(5), 2000, pp. 873-873
Authors:
Weichbold, V
Bertel, A
Pelzer, A
Pfeiffer, KP
Ferenci, P
Citation: V. Weichbold et al., Hepatitis B and C: Incidence and geographical distribution of inpatients in Austria, WIEN KLIN W, 112(23), 2000, pp. 995-1001
Authors:
Cauza, E
Ulrich-Pur, H
Polli, C
Gangl, A
Ferenci, P
Citation: E. Cauza et al., Distribution of patients with Wilson disease carrying the H1069Q mutation in Austria, WIEN KLIN W, 112(13), 2000, pp. 576-579
Authors:
Kletzmayr, J
Watschinger, B
Muller, C
Demetriou, D
Puchhammer-Stockl, E
Ferenci, P
Kovarik, J
Citation: J. Kletzmayr et al., Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients, TRANSPLANT, 70(9), 2000, pp. 1404-1407
Authors:
Schiefermeier, M
Kollegger, H
Madl, C
Polli, C
Oder, W
Kuhn, HJ
Berr, F
Ferenci, P
Citation: M. Schiefermeier et al., The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease, BRAIN, 123, 2000, pp. 585-590
Authors:
Peck-Radosavljevic, M
Wichlas, M
Zacherl, J
Stiegler, G
Stohlawetz, P
Fuchsjager, M
Kreil, A
Metz-Schimmerl, S
Panzer, S
Steininger, R
Muhlbacher, F
Ferenci, P
Pidlich, J
Gangl, A
Citation: M. Peck-radosavljevic et al., Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production, BLOOD, 95(3), 2000, pp. 795-801
Authors:
Ferenci, P
Stauber, R
Steindl-Munda, P
Gschwantler, M
Fickert, P
Datz, C
Muller, C
Hackl, F
Rainer, W
Watkins-Riedel, T
Lin, W
Citation: P. Ferenci et al., Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronichepatitis C, J VIRAL HEP, 6, 1999, pp. 53-58
Authors:
Ferenci, P
Citation: P. Ferenci, Wilson's disease, ITAL J GAST, 31(5), 1999, pp. 416-425